These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 21936899)
1. Expression of an IRF-3 fusion protein and mouse estrogen receptor, inhibits hepatitis C viral replication in RIG-I-deficient Huh 7.5 cells. Yao L; Yan X; Dong H; Nelson DR; Liu C; Li X Virol J; 2011 Sep; 8():445. PubMed ID: 21936899 [TBL] [Abstract][Full Text] [Related]
2. Identification of the IFITM3 gene as an inhibitor of hepatitis C viral translation in a stable STAT1 cell line. Yao L; Dong H; Zhu H; Nelson D; Liu C; Lambiase L; Li X J Viral Hepat; 2011 Oct; 18(10):e523-9. PubMed ID: 21914072 [TBL] [Abstract][Full Text] [Related]
3. Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes. Wang Y; Ye L; Wang X; Li J; Song L; Ho W Innate Immun; 2013; 19(2):193-202. PubMed ID: 23060457 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms. Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921 [TBL] [Abstract][Full Text] [Related]
5. Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes. Brownell J; Wagoner J; Lovelace ES; Thirstrup D; Mohar I; Smith W; Giugliano S; Li K; Crispe IN; Rosen HR; Polyak SJ J Hepatol; 2013 Oct; 59(4):701-8. PubMed ID: 23770038 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy. Binder M; Kochs G; Bartenschlager R; Lohmann V Hepatology; 2007 Nov; 46(5):1365-74. PubMed ID: 17668876 [TBL] [Abstract][Full Text] [Related]
7. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture. Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon. Breiman A; Grandvaux N; Lin R; Ottone C; Akira S; Yoneyama M; Fujita T; Hiscott J; Meurs EF J Virol; 2005 Apr; 79(7):3969-78. PubMed ID: 15767399 [TBL] [Abstract][Full Text] [Related]
9. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations. Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176 [TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes. Wang YZ; Li JL; Wang X; Zhang T; Ho WZ World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081 [TBL] [Abstract][Full Text] [Related]
11. Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes. Ye L; Wang S; Wang X; Zhou Y; Li J; Persidsky Y; Ho W Drug Alcohol Depend; 2010 Nov; 112(1-2):107-16. PubMed ID: 20646875 [TBL] [Abstract][Full Text] [Related]
12. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway. Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102 [TBL] [Abstract][Full Text] [Related]
13. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production. Xu L; Wang W; Li Y; Zhou X; Yin Y; Wang Y; de Man RA; van der Laan LJW; Huang F; Kamar N; Peppelenbosch MP; Pan Q Hepatology; 2017 Jun; 65(6):1823-1839. PubMed ID: 28195391 [TBL] [Abstract][Full Text] [Related]
14. Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes. Dansako H; Ikeda M; Kato N FEBS J; 2007 Aug; 274(16):4161-76. PubMed ID: 17651439 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines. Zhang T; Lin RT; Li Y; Douglas SD; Maxcey C; Ho C; Lai JP; Wang YJ; Wan Q; Ho WZ Hepatology; 2005 Oct; 42(4):819-27. PubMed ID: 16175599 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus reveals a novel early control in acute immune response. Arnaud N; Dabo S; Akazawa D; Fukasawa M; Shinkai-Ouchi F; Hugon J; Wakita T; Meurs EF PLoS Pathog; 2011 Oct; 7(10):e1002289. PubMed ID: 22022264 [TBL] [Abstract][Full Text] [Related]
17. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells. Plumlee CR; Lazaro CA; Fausto N; Polyak SJ Virol J; 2005 Dec; 2():89. PubMed ID: 16324217 [TBL] [Abstract][Full Text] [Related]
18. Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway. Hazari S; Chandra PK; Poat B; Datta S; Garry RF; Foster TP; Kousoulas G; Wakita T; Dash S Virol J; 2010 Feb; 7():36. PubMed ID: 20149251 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A. Vazquez C; Tan CY; Horner SM J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039 [TBL] [Abstract][Full Text] [Related]
20. Innate host response in primary human hepatocytes with hepatitis C virus infection. Yang D; Liu N; Zuo C; Lei S; Wu X; Zhou F; Liu C; Zhu H PLoS One; 2011; 6(11):e27552. PubMed ID: 22087337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]